[3P] 67 Neuroimaging/neurophysiology/neuromodeulation

[3P-464] Roles of glutamate, GABA, dopamine, and norepinephrine in a pathological basis of treatment-resistant depression

*Shiori Honda^1,2, Yoshihiro Noda^2,3, Masataka Wada^2,4, Yui Tobari², Yu Mimura², Sakiko Tsugawa^2,5, Shinsuke Koike⁶, Richard A E Edden^7,8, Clifford M Cassidy^9,10, Masaru Mimura², Hiroyuki Uchida², Shinichiro Nakajima² (1. Graduate School of Media and Governance, Keio University, Kanagawa, Japan, 2. Keio University School of Medicine, Tokyo, Japan, 3. Department of Psychiatry, International University of Health and Welfare, Mita Hospital, Tokyo, Japan, 4. Department of Psychiatry and Behavioral Sciences, Stanford University, USA., 5. Department of Physiology, Yokohama City University Graduate School of Medicine, Kanagawa, Japan, 6. Graduate School of Arts and Sciences, University of Tokyo, Japan, 7. Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. , 8. F. M. Kirby Research Center for Functional Brain Imaging, Kennedy Krieger Institute, Baltimore, Maryland, USA., 9. The Royal's Institute of Mental Health Research Affiliated with the University of Ottawa, Ottawa, Ontario, Canada. , 10. Department of Psychiatry, Renaissance School of Medicine, Stony Brook University, Stony Brook, New York, USA)

Keywords:Treatment resistant depression, glutamate, GABA, dopamine